Ultrasensitive Point-of-Care Antigen Test for Detection of Neisseria gonorrhoeae Using Plasmon-Enhanced Lateral Flow Assays
- 3 February 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Nano Medicine
- Vol. 1 (4) , 1036-1047
Abstract
No abstract availableFunding Information
- National Institute of Allergy and Infectious Diseases (R21AI178217)
- Division of Chemical, Bioengineering, Environmental and Transport Systems (2224610)
This publication has 61 references indexed in Scilit:
- Ultra-sensitive urinary lipoarabinomannan (LAM) immunoassay for tuberculosis detection: a performance evaluationEBioMedicine, 2025
- Lateral flow assay for detection and recovery of live cell Neisseria gonorrhoeaeCurrent Research in Biotechnology, 2022
- High-resolution imaging of protein secretion at the single-cell level using plasmon-enhanced FluoroDOT assayCell Reports Methods, 2022
- Characterization of urethritis-associated Neisseria meningitidis isolated from men who have sex with women in ChinaJournal of Infection, 2022
- Plasmonically-enhanced competitive assay for ultrasensitive and multiplexed detection of small moleculesBiosensors and Bioelectronics, 2021
- Fluorescent carbon nanoparticle-based lateral flow biosensor for ultrasensitive detection of DNABiosensors and Bioelectronics, 2017
- Antigen excess in modern immunoassays: To anticipate on the unexpectedAutoimmunity Reviews, 2015
- Performance of fluorescent europium(III) nanoparticles and colloidal gold reporters in lateral flow bioaffinity assayAnalytical Biochemistry, 2012
- Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature surveyAnalytical and Bioanalytical Chemistry, 2008
- Nucleic Acid Amplification Tests for Gonorrhea and Chlamydia: Practice and ApplicationsInfectious Disease Clinics of North America, 2005